Affordable Genome Sequencing for Pathogen Analysis to Address Epidemics
As genomic surveillance of COVID-19 continues, the ability of countries to contribute through rapid whole genome sequencing has become more important.
Read MorePosted by Andy Lundin | Dec 22, 2021 | Anatomic Pathology, Covid 19 |
As genomic surveillance of COVID-19 continues, the ability of countries to contribute through rapid whole genome sequencing has become more important.
Read MorePosted by Andy Lundin | Dec 22, 2021 | Covid 19, Immunoassay Reagents & test Kits |
Global medical technology company BD has completed the acquisition of privately held Scanwell Health, a provider in smartphone-enabled at-home medical tests.
Read MorePosted by Chris Wolski | Dec 20, 2021 | Sequencing Systems |
Genapsys CEO Jason Myers explains how his company is planning to solve return on investment and patient access with the company’s NGS platform.
Read MorePosted by Andy Lundin | Dec 20, 2021 | Diagnostic Technologies, Molecular Diagnostic Analyzers |
BD has expanded its BD COR System to include a new MX instrument for high-throughput molecular testing for infectious diseases.
Read MorePosted by Andy Lundin | Dec 17, 2021 | Sequencing Systems |
Singular Genomics Systems launched its G4 benchtop sequencer for commercial use in a range of applications, such as research in oncology and immunology.
Read More